World's Best Scientists 2026 revealed!
Leukemia Research Reports
H-index 5

Leukemia Research Reports

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 3116 38 36 4

Additional Metrics

Number of Best Scientists*: 67
Documents by Best Scientists*: 56
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 17
SCIMAGO SJR: 0.322
Impact Factor: N/A

Overview

Top Research Topics at Leukemia research reports?

The journal primarily focuses on research topics in Internal medicine, Myeloid leukemia, Oncology, Immunology and Cancer research. The studies tackled, which mainly focus on Internal medicine, apply to Gastroenterology as well. The studies in Myeloid leukemia featured incorporate elements of Chromosomal translocation, Myeloid, ABL and Leukemia, Acute leukemia.

Some problems in Oncology that were presented in Leukemia research reports overlapped with concepts under Myelodysplastic syndromes, Azacitidine and Lenalidomide. Immunology study tackled is connected to the field of Hematopoietic stem cell transplantation. In the journal, Phenotype, Chronic myelomonocytic leukemia and Pathogenesis are investigated in conjunction with one another to address concerns in Cancer research research.

The journal focused on Chemotherapy research but expanded to cover Lymphoma. Lymphoma research discussed in it aim to provide more information in the subject of Pathology. The study on Transplantation presented is investigated in conjunction with research in Stem cell.

  • Internal medicine (43.28%)
  • Myeloid leukemia (30.22%)
  • Oncology (25.37%)

What are the most cited papers published in the journal?

  • Acute myeloid leukemia in the older adults (82 citations)
  • An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes (61 citations)
  • Mcl-1 as a Therapeutic Target in Acute Myelogenous Leukemia (AML) (57 citations)

Research areas of the most cited articles at Leukemia research reports:

The most cited publications mainly tackle studies in Immunology, Myeloid leukemia, Internal medicine, Mutation and Cancer research. The published articles explore Immunology concepts, specifically Chronic lymphocytic leukemia but expand to research in Oncogene. Most of the works presented in the most cited papers deal with Internal medicine but they intersect with the subject of Oncology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Gene

The previous edition focused in particular on these issues:

The journal primarily tackles Internal medicine, Oncology, Cancer research, Myeloid leukemia and Leukemia. The journal holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology and Stem cell. The concepts on Oncology presented in the journal can also apply to other research fields, including Disease, Refractory and Transplantation.

While the journal focused on Cancer research, it was also able to explore topics like Phenotype, Ibrutinib and Bone marrow. Topics in Myeloid leukemia explored in it were investigated in conjunction with research in Drug, Toxicity and Induction chemotherapy. Leukemia research presented in Leukemia research reports encompasses a variety of subjects, including Essential thrombocythemia, Stool culture, Enterocolitis and Molecular diagnostics.

The most cited articles from the last journal are:

  • Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges. (1 citations)
  • Treatment outcome of doxorubicin versus idarubicin in adult acute myeloid leukemia (0 citations)
  • Promising Remissions in Relapsed Refractory Classical Hodgkin Lymphoma Patients Requiring Multiple Salvage Regimens before Transplantation in the Brentuximab Vedotin Era (0 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Leukemia research reports (based on the number of publications) are:

  • Aya Nakaya (7 papers) absent at the last edition,
  • Kazuyoshi Ishii (6 papers) absent at the last edition,
  • Yoshiko Azuma (6 papers) absent at the last edition,
  • Masaaki Hotta (6 papers) absent at the last edition,
  • Hideaki Yoshimura (6 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Leukemia research reports (based on the number of publications) are:

  • Mayo Clinic (9 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Kansai Medical University (7 papers) absent at the last edition,
  • Memorial Sloan Kettering Cancer Center (6 papers) absent at the last edition,
  • Roswell Park Cancer Institute (6 papers) absent at the last edition,
  • Aarhus University Hospital (5 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 8.89% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 17.07% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.76% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 29.27% of all publications and 43.90% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Nursing as a Career Perspective

The article also highlights the importance of nursing in dealing with leukemia patients, particularly in the area of post-chemotherapy care and hematopoietic stem cell transplantation. As cancer research continues to grow and evolve, the role of nurses has become increasingly important. They are usually the first point of contact for patients and play a crucial part in their care, treatment, and recovery. They not only administer medications and treatments but also provide emotional support, educate patients about their condition, and help them make informed decisions. Studying to become a nurse requires a solid commitment to rigorous coursework and practical training. For those who are interested in pursuing a nursing career with a specialization in Hematology, it is essential to complete a bachelor's degree in nursing, successfully pass the National Council Licensure Examination for Registered Nurses (NCLEX-RN), and gain clinical experience in Hematology. Advanced education options and specialized certifications are also available, which can help improve career prospects and provide opportunities for higher-level roles. Different states have different requirements for becoming a registered nurse. For instance, for those who wish to become registered nurses in Hawaii, there are specific guidelines and steps to follow. For detailed information, you can refer to this comprehensive guide on how to become a registered nurse in Hawaii online. Nursing can be an extremely rewarding career, especially when you can make a difference in the lives of people suffering from diseases like leukemia. With the right knowledge, training, and dedication, nurses can substantially contribute to the medical field and make significant impacts on patients' lives.

Top Publications

  • Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)

    (2022)
    17 Citations
  • Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax.

    Maria Tariq Siddiqui;Allyson Price;Alessandra Ferrajoli;Gautam Borthakur

    (2021)
    6 Citations
  • Management of multiple myeloma during COVID-19 pandemic

    YS Jethava;Rafael Fonseca;Ola Landgren

    (2020)
    6 Citations
  • Therapy-related B-lymphoblastic leukemia after multiple myeloma

    (2022)
    5 Citations
  • Case of Pulmonary Extramedullary Hematopoiesis Responding to Ruxolitinib

    (2022)
    4 Citations
  • CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis

    (2022)
    3 Citations
  • Successful Treatment of Ocular Chronic Lymphocytic Leukemia with Ibrutinib: Case Report and Review of the Literature.

    Ayushi F Chauhan;Narine Viruni;T.Y. Alvin Liu;J Fernando Arevalo

    (2020)
    3 Citations
  • Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantation.

    Mireille Hunziker;Jakob Passweg;Michael Medinger

    (2021)
    2 Citations
  • Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning

    (2022)
    2 Citations
  • Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma

    (2022)
    2 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical knowledge or advancing their career, various online programs offer flexible options. For example, a 1 year pmhnp program provides a streamlined path for nurses aiming to specialize as Psychiatric Mental Health Nurse Practitioners within a short timeframe. This is ideal for professionals seeking career growth without extensive time commitments.

Similarly, post masters fnp programs enable nurses who already hold a master's degree to become Family Nurse Practitioners through focused online coursework. These programs bridge the gap between education and practice, catering to working professionals.

Beyond nursing, aspiring healthcare professionals may explore nutrition by enrolling in an online nutritionist degree. This option supports careers in dietetics and wellness, offering affordable and accessible education that aligns with growing industry demands.

For registered nurses looking to advance their qualifications, rn to bsn programs provide a flexible and convenient pathway to earn a Bachelor of Science in Nursing. These programs are designed to accommodate working professionals while enhancing clinical and leadership skills.

Best Scientists Contributing to This Journal

Recently Published Articles